We are biotech investor experts, so we know how to prepare press releases and news pitches that get the attention of biotech and investor journalists who are opinion leaders and trusted by the investor community.
Our press releases are AI-targeted so we can get your news to the right media and, thus, to the right audiences—investors, partners, M&A opportunities, and more.